Use of NSAIDS compared to paracetamol as potential risk factors for asthma

A. Marquis, M. P. F. Strippoli, C. E. Rebholz, B. D. Spycher, N. X. von der Weid, C. E. Kuehni (Bern, Lausanne, Switzerland)

Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma
Session: Paediatric respiratory epidemiology: early origins of childhood asthma
Session type: E-Communication Session
Number: 3788
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Marquis, M. P. F. Strippoli, C. E. Rebholz, B. D. Spycher, N. X. von der Weid, C. E. Kuehni (Bern, Lausanne, Switzerland). Use of NSAIDS compared to paracetamol as potential risk factors for asthma. Eur Respir J 2010; 36: Suppl. 54, 3788

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Compliance to asthma treatment and its risk factors
Source: Eur Respir J 2005; 26: Suppl. 49, 508s
Year: 2005

Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016
Year: 2017



Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005

Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Overuse of short-acting beta-agonists (SABA) and risk factors among patients with asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Late Breaking Abstract - Overuse of oral corticosteroids in asthma – modifiable factors and potential role of biologics
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019



Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018

Potential drugs to treat smokers with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007



The effects of inhaled corticosteroids on risk of self-reported osteoporosis and fractures in adult subjects with asthma
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017


Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


Prescribed analgesics in pregnancy and risk of childhood asthma
Source: Eur Respir J, 53 (5) 1801090; 10.1183/13993003.01090-2018
Year: 2019



The effect of risk factors on the frequency of asthma attacks
Source: Eur Respir J 2005; 26: Suppl. 49, 682s
Year: 2005

Estimation of risk of osteoporosis based on inhaled and oral corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002

Factors affecting adherence to prescribed asthma treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 80s
Year: 2002

Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD
Source: Eur Respir J 2010; 36: 494-502
Year: 2010



Statin use associated with reduced risk of asthma: a meta-analysis
Source: International Congress 2019 – Asthma and the world
Year: 2019

Frequent use of paracetamol and risk of allergic diseases among women in an Ethiopian population
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010

Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
Source: Eur Respir Rev, 26 (145) 160123; 10.1183/16000617.0123-2016
Year: 2017



The risk of cardiovascular disease associated with asthma may be mediated by short-acting β2-agonists
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008